AstraZeneca PLC (AZN.L)

LSE - LSE Delayed Price. Currency in GBp
5,002.00+47.00 (+0.95%)
As of 12:14 PM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close4,955.00
Bid4,890.00 x 20700
Ask5,100.00 x 15300
Day's Range4,962.00 - 5,109.63
52wk Range3,680.00 - 5,505.00
1y Target EstN/A
Market Cap63.27B
P/E Ratio (ttm)28.58
Avg Vol (3m)2,853,342
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Financial Times7 hours ago

    [$$] We need more players to tackle antibiotic resistance

    Sir, AstraZeneca has entered into an agreement with Pfizer to sell the development and commercialisation rights to its late-stage small molecule antibiotics business ("AstraZeneca in $1.6bn antibiotic ...

  • Reuters7 hours ago

    AstraZeneca to pay $5.52 million to resolve SEC foreign bribery case

    The U.S. Securities and Exchange Commission detailed the settlement with the London-based drug company in an order instituting an administrative proceeding arising out of violations of provisions in the Foreign Corrupt Practices Act. AstraZeneca, which cooperated with the probe, neither admitted nor denied wrongdoing.

  • 24/7 Wall St.2 days ago

    Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

    Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.